Cilastatin

Mechanism of action:
Cilastatin is a renal dehydropeptidase-I inhibitor. Its main function is to protect β-lactam antibiotics such as imipenem from renal metabolism and inactivation, so it is used almost exclusively in combination with imipenem. Dehydropeptidase-I is an enzyme located on the brush border of the renal proximal tubule and can hydrolyze antibiotics containing a β-lactam ring, especially imipenem. When imipenem is given alone, a substantial portion is degraded and inactivated in the kidney by dehydropeptidase-I. Cilastatin reversibly inhibits dehydropeptidase-I activity, allowing imipenem to retain its therapeutic effect.
Reference(s):
1. Keynan S et al. (1995). The renal membrane dipeptidase (dehydropeptidase I) inhibitor, cilastatin, inhibits the bacterial metallo-beta-lactamase enzyme CphA. Antimicrob Agents Chemother.
2. Buckley MM et al. (1992). Imipenem/cilastatin: A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs.
3. Balfour JA et al. (1996). Imipenem/cilastatin: An update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections. Drugs.
